Stryker’s Biotech Unit Gets FDA Warning Letter
CHICAGO (Reuters) - Stryker Corp <SYK.N> said on Friday its
biotechnology division received a warning letter from U.S.
health regulators regarding quality systems and compliance
issues at its Hopkinton, Massachusetts, location.